MindMed to Host Conference Call and Webcast to Discuss Second Quarter 2024 Financial Results and Provide Business Update
06 August 2024 - 9:00PM
Business Wire
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or
“MindMed”), a clinical-stage biopharmaceutical company developing
novel product candidates to treat brain health disorders, announced
today that it plans to host a conference call on Tuesday, August
13, 2024, at 8:00 a.m. ET to provide a corporate update and review
the Company’s results for the second quarter ended June 30,
2024.
Listeners can register for the webcast via this link. Analysts
wishing to participate in the question and answer session should
use this link. A replay of the webcast will be available via the
Investor Relations section of the MindMed website,
https://ir.mindmed.co/, and archived for at least 30 days after the
webcast. Those who plan on participating are advised to join 15
minutes prior to the start time.
About MindMed
MindMed is a clinical-stage biopharmaceutical company developing
novel product candidates to treat brain health disorders. Our
mission is to be the global leader in the development and delivery
of treatments that unlock new opportunities to improve patient
outcomes. We are developing a pipeline of innovative product
candidates, with and without acute perceptual effects, targeting
neurotransmitter pathways that play key roles in brain health
disorders. MindMed trades on NASDAQ under the symbol MNMD.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240806368517/en/
For Media: media@mindmed.co For Investors:
ir@mindmed.co
Mind Medicine MindMed (NASDAQ:MNMD)
Historical Stock Chart
From Sep 2024 to Oct 2024
Mind Medicine MindMed (NASDAQ:MNMD)
Historical Stock Chart
From Oct 2023 to Oct 2024